Stryper frontman Michael Sweet has received a new directive from his medical team regarding his battle with papillary thyroid cancer. Just weeks after revealing that the disease had returned—this time in the remaining right lobe of his thyroid—the vocalist shared a significant update on Christmas Eve, announcing that he will not be undergoing surgery immediately.
Instead, doctors have determined that Sweet is a “prime candidate” for a medical strategy known as “active surveillance.” This approach is often used for small, slow-growing cancers where the risks of surgical intervention outweigh the immediate threat posed by the tumor.
Taking to social media on Wednesday, December 24, Sweet explained the situation to his fans, noting that while the nodule is indeed malignant, its containment allows for a less invasive approach for the time being.
“I wanted to give you all an update. I met with my doctor/team and apparently I’m a prime candidate for ‘active surveillance’. What that means is they’re going to do an ultrasound in 6 months to see if there has been any change to the nodule in my right thyroid,” Sweet wrote.
“It is malignant, but the good news is it’s self contained and surrounded by healthy tissue. It’s also small enough that they feel it makes more sense to ‘keep an eye on it’ instead of rushing surgery at this point in time. They feel that surgery itself is more risky than the nodule itself. At least for now. So, I’ll have an ultrasound in June and we’ll go from there. My hopes and prayers are to see it disappear. Maybe through diet, hope and prayers, it will.”
He concluded his message with gratitude for the outpouring of support he has received since the initial diagnosis: “Thank you all for taking the time to think of me and to prayer for me. It’s comforting to know that there are so many friends out there and I love you all.”
This latest development marks a shift in the expected treatment plan. Only two weeks ago, during an appearance on SiriusXM‘s “Trunk Nation With Eddie Trunk, Sweet seemed resigned to the inevitability of another operation. He revealed that his thyroid issues have been a decade-long struggle, culminating in a partial thyroidectomy two years ago to remove a malignant nodule on the left side.
“I went in and got checked and they scoped me and did an ultrasound and they discovered that I had some nodules on my thyroid on each side,” Sweet told host Eddie Trunk. “And they just kept an eye on those for a number of years. And they got bigger… the one on my left side, got large enough where they wanted to biopsy it, and it came back malignant. I had surgery two years ago to have that removed.”
While the right side was initially deemed safe despite Sweet suffering from Hashimoto’s disease (a chronic autoimmune condition), recent tests showed concerning changes.
“There was some new calcification in that nodule and they did a biopsy and it came back malignant. So I gotta go through it again,” he had stated at the time.
In that same interview, Sweet expressed a strong desire to be proactive, dismissing alternative treatments in favor of surgical removal to prevent metastasis.
“I’ve got all these people who… are reaching out to me about holistic medicine and natural healing and this and that. And to be honest with you, I just wanna get it out of there. And I don’t wanna mess around with it,” Sweet admitted earlier this month. “It’s papillary, slow growing. It’s at a stage where I’m okay, but if I ignore it and I’m not proactive, it’ll get to a point where it will eventually spread, and then I’ve got real issues.”
However, the medical consensus has now pivoted. The doctors’ assessment that “surgery itself is more risky than the nodule” suggests that the potential complications of operating on the remaining thyroid tissue—which can impact vocal cords and calcium regulation—are currently a greater concern than the slow progression of the cancer.
